These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30029630)

  • 1. Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol.
    Reddy S; Nair NP; Giri S; Mohan VR; Tate JE; Parashar UD; Gupte MD; Arora R; Kang G;
    BMC Public Health; 2018 Jul; 18(1):898. PubMed ID: 30029630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intussusception after Rotavirus Vaccine Introduction in India.
    Reddy SN; Nair NP; Tate JE; Thiyagarajan V; Giri S; Praharaj I; Mohan VR; Babji S; Gupte MD; Arora R; Bidari S; Senthamizh S; Mekala S; Goru KB; Reddy B; Pamu P; Gorthi RP; Badur M; Mohan V; Sathpathy S; Mohanty H; Dash M; Mohakud NK; Ray RK; Mohanty P; Gathwala G; Chawla S; Gupta M; Gupta R; Goyal S; Sharma P; Mathew MA; Jacob TJK; Sundaram B; Purushothaman GKC; Dorairaj P; Jagannatham M; Murugiah K; Boopathy H; Maniam R; Gurusamy R; Kumaravel S; Shenoy A; Jain H; Goswami JK; Wakhlu A; Gupta V; Vinayagamurthy G; Parashar UD; Kang G
    N Engl J Med; 2020 Nov; 383(20):1932-1940. PubMed ID: 33176083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis.
    INCLEN Intussusception Surveillance Network Study Group
    Vaccine; 2021 Jan; 39(1):78-84. PubMed ID: 32972735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Intussusception Hospitalizations in Children Under 2 Years of Age Post Rotavirus Vaccine Introduction in Tamil Nadu and Puducherry, India.
    Kumar CPG; N SR; Subramanian S; Shenoy A; Maniam R; Dorairaj P; Ramasubramaniam P; Thiyagarajan V; Kulandaivel M; Guruswamy R; Kumar BH; Selvarajan N; Kumaran JM; Sundaram B; Kumaravel S
    Indian J Pediatr; 2021 Mar; 88(Suppl 1):124-130. PubMed ID: 33469897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccine impact assessment surveillance in India: protocol and methods.
    Nair NP; Reddy N S; Giri S; Mohan VR; Parashar U; Tate J; Shah MP; Arora R; Gupte M; Mehendale SM; ; Kang G
    BMJ Open; 2019 Apr; 9(4):e024840. PubMed ID: 31028037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system.
    Early Rollout of ROTAVAC®India Network
    Vaccine; 2020 Jul; 38(33):5241-5248. PubMed ID: 32553493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
    Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
    Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intussusception hospitalizations before rotavirus vaccine introduction: Retrospective data from two referral hospitals in Tamil Nadu, India.
    Srinivasan R; Girish Kumar CP; Naaraayan SA; Jehangir S; Thangaraj JWV; Venkatasubramanian S; Kang G
    Vaccine; 2018 Dec; 36(51):7820-7825. PubMed ID: 29199044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intussusception in southern India: comparison of retrospective analysis and active surveillance.
    Jehangir S; John J; Rajkumar S; Mani B; Srinivasan R; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A99-103. PubMed ID: 25091689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India.
    John J; Kawade A; Rongsen-Chandola T; Bavdekar A; Bhandari N; Taneja S; Antony K; Bhatnagar V; Gupta A; Kabra M; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A104-9. PubMed ID: 25091662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Intussusception with Rotavirus Vaccine.
    Kalaiselvan V; Thota P; Kumar V; Rathore MS; Thota A; Singh GN
    Indian J Pediatr; 2017 Feb; 84(2):97-100. PubMed ID: 27641974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intussusception Rate Among Under-Five-Children Before Introduction of Rotavirus Vaccine in North India.
    Gupta M; Kanojia R; Singha R; Tripathy JP; Mahajan K; Saxena A; Bansal A; Muralidharan J; Kumar R
    J Trop Pediatr; 2018 Aug; 64(4):326-335. PubMed ID: 29040742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
    Puliyel J; Hooker BS
    Int J Risk Saf Med; 2024; 35(3):207-215. PubMed ID: 38875047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
    Lloyd-Johnsen C; Justice F; Donath S; Bines JE
    Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination?
    Bruun T; Watle SSV; Tveteraas IH; Flem E
    Vaccine; 2019 Sep; 37(38):5717-5723. PubMed ID: 31255303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective surveillance for intussusception in children aged less than five years at two tertiary care centers in India.
    Singh JV; Kamath V; Shetty R; Kumar V; Prasad R; Saluja T; Dhingra MS
    Vaccine; 2014 Aug; 32 Suppl 1():A95-8. PubMed ID: 25091688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood Intussusception after Introduction of Indigenous Rotavirus Vaccine: Hospital-Based Surveillance Study from Odisha, India.
    Pradhan SK; Dash M; Ray RK; Mohakud NK; Das RR; Satpathy SK; Chaudhury J; Prusty JB; Padhi PS; Mohanty SK; Das M; Reddy N S; Nayak MK
    Indian J Pediatr; 2021 Mar; 88(Suppl 1):112-117. PubMed ID: 33544368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
    Carlin JB; Macartney KK; Lee KJ; Quinn HE; Buttery J; Lopert R; Bines J; McIntyre PB
    Clin Infect Dis; 2013 Nov; 57(10):1427-34. PubMed ID: 23964090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial.
    Kanungo S; Chatterjee P; Bavdekar A; Murhekar M; Babji S; Garg R; Samanta S; Nandy RK; Kawade A; Boopathi K; Kanagasabai K; Kamal VK; Kumar VS; Gupta N; Dutta S
    Lancet Infect Dis; 2022 Aug; 22(8):1191-1199. PubMed ID: 35588754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants.
    Chilengi R; Mwila-Kazimbaya K; Chirwa M; Sukwa N; Chipeta C; Velu RM; Katanekwa N; Babji S; Kang G; McNeal MM; Meyer N; Gompana G; Hazra S; Tang Y; Flores J; Bhat N; Rathi N
    Vaccine; 2021 Jun; 39(27):3633-3640. PubMed ID: 33992437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.